Rejox™ Skin Lightening Cream – With New Imported Formula (30g)
₨1,850
Payment Methods:

Description
Rejox™ Skin Lightening Cream is crafted with a new imported formula that combines advanced skin science and nourishing ingredients to visibly lighten dark spots, even skin tone, and restore natural glow. Suitable for all skin types, it helps reduce pigmentation, blemishes, and discoloration while keeping the skin soft and healthy.
Key Features & Benefits
Visibly lightens skin tone and brightens complexion
Fades dark spots, blemishes, and pigmentation
Formulated with new imported ingredients for enhanced performance
Smooth, non-greasy texture that absorbs easily
Hydrates and softens skin without clogging pores
Suitable for men and women
Why Use Rejox™ Cream?
Designed for those looking to reduce uneven skin tone and dullness
Ideal for daily use to maintain glowing, clear skin
Combats pigmentation from sun exposure, acne scars, and aging
Safe for use on face, neck, and hands
Delivers visible results with consistent use
How to Use
Wash your face and gently pat dry
Apply a thin layer to the face or targeted areas
Use twice daily—morning and night—for best results
Follow up with sunscreen during the day
Things to Avoid
Do not apply on broken, irritated, or peeling skin
Avoid mixing with other lightening treatments unless directed
Keep out of reach of eyes and mouth
Discontinue use if redness, itching, or burning occurs
Store in a cool, dry place away from sunlight…
Customer Reviews
Related Products
MAYBELLINE NEW YORK FIT me (MATT+PORELESS) + 16H OIL CONTROL SPF22 (120)
In stock
MAYBELLINE NEW YORK FIT me (MATT+PORELESS) + 16H OIL CONTROL SPF22 (115)
In stock
CONTACT DETAILS
- Shop #3,4 Chaudhary Plaza Dhama moor Main adiyala road Rawalpindi
-
03125059372
0515561209 - info@shazeenpharmacy.com
- Customer Support: 7 Days a Week, 10:00AM - 10:00PM
Quick Links
Useful Links
SUBSCRIBE OUR NEWSLETTER
Get the latest offers and promotions!
Copyright © 2025 Shazeen Chemist. All rights reserved.

Reviews
Clear filtersThere are no reviews yet.